Emily English

Insider Reports History

Location
Gaithersburg, MD
Signature
/s/ Matthew Bartholomae, Attorney-in-Fact for Emily English
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Emily English:

Company Role Class Num Shares Value Price $ Report Date Ownership
Cartesian Therapeutics, Inc. Chief Operations Officer Common Stock 70,226 $231,745 $3.30 30 Dec 2025 Direct
Cartesian Therapeutics, Inc. Chief Operations Officer Stock Option (Right to Buy) 19,369 $39,002 $0.7900 30 Dec 2025 Direct
Cartesian Therapeutics, Inc. Chief Operations Officer Employee Stock Option (right to buy) 47,400 02 Jan 2025 Direct

Insider Reports Filed by Emily English

Symbol Company Period Transactions Value $ Form Type Role Filing Time
RNAC Cartesian Therapeutics, Inc. 30 Dec 2025 2 +$24,750 4 Chief Operations Officer 02 Jan 2026, 16:03
RNAC Cartesian Therapeutics, Inc. 28 Nov 2025 2 +$24,750 4 Chief Operations Officer 02 Dec 2025, 16:02
RNAC Cartesian Therapeutics, Inc. 12 May 2025 2 +$24,750 4 Chief Operations Officer 14 May 2025, 16:15
RNAC Cartesian Therapeutics, Inc. 15 Apr 2025 2 +$24,750 4 Chief Operations Officer 16 Apr 2025, 16:35
RNAC Cartesian Therapeutics, Inc. 03 Jan 2025 2 -$30,149 4 Chief Operations Officer 07 Jan 2025, 20:05
RNAC Cartesian Therapeutics, Inc. 02 Jan 2025 2 $0 4 Chief Operations Officer 06 Jan 2025, 16:21
RNAC Cartesian Therapeutics, Inc. 26 Dec 2024 2 +$25,245 4 SVP, Head of Manufacturing 30 Dec 2024, 16:11
RNAC Cartesian Therapeutics, Inc. 09 Apr 2024 0 $0 3 SVP, Head of Manufacturing 19 Apr 2024, 16:49